These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39047144)

  • 1. The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma?
    Lei L; Hong Qing S; Wei L; Ma Mo Yang F; Xiao Xiang Y
    Am Surg; 2024 Dec; 90(12):3209-3215. PubMed ID: 39047144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China.
    Lan Z; Yang F; Zhang J; Lan Y; Li H; He R
    Acta Cytol; 2023; 67(6):629-638. PubMed ID: 37708867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of combined
    Zhou B; Zhai YF; Zhang DY; Wang DQ; Wei L; Qin JW
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Nov; 55(11):1057-1062. PubMed ID: 33210886
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules.
    Beiša A; Kvietkauskas M; Beiša V; Stoškus M; Ostanevičiūtė E; Jasiūnas E; Griškevičius L; Šeinin D; Šileikytė A; Strupas K
    Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):247-254. PubMed ID: 29566402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic Value of American Thyroid Association Guidelines,American College of Radiology Thyroid Imaging Reporting and Data System,and Chinese Thyroid Imaging Reporting and Data System Alone and Combined With BRAF
    Lin Y; Luo YK; Li J; Ren XY; Wang HW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):921-928. PubMed ID: 38173102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF
    Chen H; Song A; Wang Y; He Y; Tong J; Di J; Li C; Zhou Z; Cai X; Zhong D; Da J
    Cancer Med; 2022 Jan; 11(1):40-49. PubMed ID: 34851044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
    Adeniran AJ; Hui P; Chhieng DC; Prasad ML; Schofield K; Theoharis C
    Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk Stratification of Papillary Thyroid Cancer With Bethesda Category III (Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance) by Thyroid Fine-Needle Aspiration Could Be Assisted by Tumor Size for Precision Treatment.
    Zha X; Miao Z; Huang X; Wang X; Xie R; Jin J; Zou D; Yang P; Huang Y
    Front Endocrinol (Lausanne); 2022; 13():822423. PubMed ID: 35197932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
    Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
    Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
    Hyeon J; Ahn S; Shin JH; Oh YL
    Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
    Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of BRAF V600E in Reducing AUS/FLUS Diagnosis in Thyroid Fine Needle Aspiration.
    Yin L; Tang Y; Yu S; Wang C; Xiao M; Wang Y; Liu SJ; Gao L; Huang K; Jin L
    Endocr Pathol; 2019 Dec; 30(4):312-317. PubMed ID: 31529211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Clinical Usefulness of BRAFV600E Mutation Analysis of Core-Needle Biopsy Specimens in Thyroid Nodules with Previous Atypia of Undetermined Significance or Follicular Lesions of Undetermined Significance Results.
    Choi SH; Baek JH; Lee JH; Choi YJ; Song DE; Chung KW; Kim TY; Shong YK
    Thyroid; 2015 Aug; 25(8):897-903. PubMed ID: 25978151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.
    Paek SH; Kim BS; Kang KH; Kim HS
    World J Surg Oncol; 2017 Nov; 15(1):202. PubMed ID: 29132392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction Table and Nomogram as Tools for Diagnosis of Papillary Thyroid Carcinoma: Combined Analysis of Ultrasonography, Fine-Needle Aspiration Biopsy, and BRAF V600E Mutation.
    Kim SK; Lee JH; Woo JW; Park I; Choe JH; Kim JH; Kim JS
    Medicine (Baltimore); 2015 May; 94(21):e760. PubMed ID: 26020381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of BRAF V600E mutation detection of fine-needle aspiration biopsy on diagnosis and treatment guidance of papillary thyroid carcinoma.
    Qi W; Shi C; Zhang P; Feng L; Wang J; Chen D
    Pathol Res Pract; 2020 Aug; 216(8):153037. PubMed ID: 32703500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of the detection of
    Zhao H; Guo HQ; Zhang ZH; Cao J; Zhao LL; Sun Y; Wang C; Xiao T
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):18-22. PubMed ID: 30704164
    [No Abstract]   [Full Text] [Related]  

  • 18. Value of
    Chen X; Zhou Q; Wang F; Zhang F; Du H; Zhang Q; Wu W; Gong X
    AJNR Am J Neuroradiol; 2018 Dec; 39(12):2360-2365. PubMed ID: 30498021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
    Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G
    Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of the Bethesda category and its association with BRAF mutation in the prediction of papillary thyroid cancer stage.
    Beiša A; Kvietkauskas M; Beiša V; Stoškus M; Ostanevičiūtė E; Jasiūnas E; Griškevičius L; Strupas K
    Langenbecks Arch Surg; 2017 Mar; 402(2):227-234. PubMed ID: 28160058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.